Unnamed Foreign Intelligence Sources

ATLANTA, Geórgia (CNN) -- the food and the administration of the drug monday emitted an acknowledgment to the users of the pacifying to over-the-counter of after federal investigating pain naproxen found an increased number of attacks and courses of heart between users. The acknowledgment followed the recent studies that bind two drugs of the arthritis of the lapsing to the problems cardiovascular. Naproxen, vendido under the name of Aleve type, was part of a study for the national justinian codes of the health in if naproxen or the Celebrex drug of the arthritis could be used to deal with the illness Alzheimer. The NIH investigators had after stopped the examination having joined the peoples who had made examination naproxen were 50 percent more probable to have heart attacks or courses (full history) the FDA stirred up users to contact its doctors and to prevent them to make examination of the drug for more for much time of 10 days. Helmut Schdefers, one spokesman for Healthcare GAC of Bayer, manufacturers of Aleve, said that the company estêve informed behind night of monday on the tests. The company still did not see the data, said the CNN, but it is investigating the substance. "we are in the agreement with regulators of the FDA that the peoples who make examination of Aleve must consult its doctors and prevent them for more than to make examination of the drug 10 days," it we said. "Aleve is disturbing particularly because it is a drug to over-the-counter," the investigator of the security of the drug of the FDA and whistleblower David said CNN's Graham "American morning," "drugs to over-the-counter are presumptions to be these that are the absolutely safest ones." The NIH study the last week seemed contradict a national study of the institute of cancer that found that the users of Celebrex had more had a raised risk of the attack or the course of heart. The NIH did not find a higher probability of those problems in users of Celebrex. Friday, the FDA warned doctors to consider "the alternative therapy" for the patients who make examination of Celebrex later that the investigators of cancer had found cardiovascular a higher risk of problems between the patients who make examination of the drug. The indication of the FDA said one other painkiller, Bextra, also showed increased risks of events cardiovascular after the surgery of the heart. Findings of the last week the Merck manufacturer of the drug had come two months more than had after remembered a similar drug of the arthritis, Vioxx, after similar results. Merck now faces hundreds of lawsuits and potential of billions of the dollars in the damages. Vioxx, Bextra and Celebrex are of a family of the known drugs as the Cox-2 inhibitors, that had been announced heavily the potential patients. Pfizer pulled ads for Celebrex, but it disputed findings and it kept the drug in the market for now. Graham said that the recent editions that surround medications point to the problems biggest in the FDA, such as a lack of accountability of the agency. The agency remains, said it, in the negation on problems with the way that the drugs are approved. "I think that this makes the question biggest, ' because it has the FDA not made the work that needs to make to protect America of the unsafe drugs ' "he said. Graham said in its 20 years in the FDA, the "security estêve in the back part of the bar-bus, if was in the bar-bus in everything."